Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies - Document - Gale Academic OneFile
![PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602 PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602](https://image3.slideserve.com/5660602/slide24-l.jpg)
PPT - Allison Weddington, PharmD PGY1 Pharmacy Resident St. Louis Children's Hospital November 14, 2011 PowerPoint Presentation - ID:5660602
![The clinical management of tumour lysis syndrome in haematological malignancies - Will - 2011 - British Journal of Haematology - Wiley Online Library The clinical management of tumour lysis syndrome in haematological malignancies - Will - 2011 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a98512ca-4e25-4242-99d6-168b054f3f59/bjh_8697_f1.gif)
The clinical management of tumour lysis syndrome in haematological malignancies - Will - 2011 - British Journal of Haematology - Wiley Online Library
![Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.leu.2402847/MediaObjects/41375_2003_Article_BF2402847_Fig1_HTML.jpg)
Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia
![Figure 1 from Urate oxidase (rasburicase) for treatment of severe tophaceous gout. | Semantic Scholar Figure 1 from Urate oxidase (rasburicase) for treatment of severe tophaceous gout. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1b304372909e78e951a607b7a575e9d479fe1c75/2-Figure1-1.png)
Figure 1 from Urate oxidase (rasburicase) for treatment of severe tophaceous gout. | Semantic Scholar
![Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0272638609015649-gr3.jpg)
Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and Management - ScienceDirect
![Figure 4 | An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review Figure 4 | An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review](https://static-02.hindawi.com/articles/crim/volume-2012/468452/figures/468452.fig.004.jpg)
Figure 4 | An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review
![Purine catabolic pathway and site of action of allopurinol and rasburicase. | Download Scientific Diagram Purine catabolic pathway and site of action of allopurinol and rasburicase. | Download Scientific Diagram](https://www.researchgate.net/publication/26767487/figure/fig1/AS:203189069586443@1425455457407/Purine-catabolic-pathway-and-site-of-action-of-allopurinol-and-rasburicase.png)
Purine catabolic pathway and site of action of allopurinol and rasburicase. | Download Scientific Diagram
![Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2402847/MediaObjects/41375_2003_Article_BF2402847_Fig2_HTML.gif)
Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 | Leukemia
![A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia - ScienceDirect A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0145212621000898-gr1.jpg)